10
Sponsors
Ziekenhuis Aan De Stroom, Universitaetsklinikum Schleswig-Holstein, Rheinische Friedrich-Wilhelms-Universitaet Bonn, Inmunotek S.L.
Conditions
Grass pollen induced moderate-to-severe allergic rhinitis or rhinoconjunctivitis with or without mild-to-moderate asthmaOverweight or ObesityPolycystic Ovary Syndrome (PCOS)Prostate canceracute lymphoblastic leukemia in children and adolescents
Phase 2
Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers (THUNDER): A Two-part Phase 2/3 Trial
RecruitingCTIS2022-501551-90-00
Start: 2023-12-13Target: 583Updated: 2026-01-23
A phase II, randomized, open-label study comparing salvage radiotherapy in combination with 6 months of androgen-deprivation therapy (ADT) with LHRH agonist or antagonist versus anti-androgen therapy (AAT) with apalutamide in patients with biochemical progression after radical prostatectomy
Not yet recruitingCTIS2024-512023-37-00
Target: 202Updated: 2025-09-11
Phase 3
AIEOP-BFM ALL 2017 - International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia
Active, not recruitingCTIS2023-509856-32-00
Start: 2018-07-15Target: 4250Updated: 2025-08-19
A prospective, randomized, double-blind, placebo-controlled, multicenter clinical trial to evaluate the efficacy and safety of subcutaneous immunotherapy with polymerized grass pollen extracts in patients with grass pollen–induced allergic rhinitis/rhinoconjunctivitis with or without mild-to-moderate asthma
Not yet recruitingCTIS2026-526100-73-00
Target: 171Updated: 2026-10-01